AuntMinnie
MARCH 26, 2025
Lead on the research, Vani Vijayakumar, MD, chief of nuclear medicine at Ochsner Medical Center in New Orleans, noted that radium-223 opened the door for TAT, with the approval in 2013 of radium-223 dichloride (Ra-223, Xofigo) for patients with advanced prostate cancer.
AuntMinnie
MARCH 26, 2024
Food and Drug Administration's (FDA) approvals of radiopharmaceuticals for neuroendocrine tumors and then for prostate cancer, theranostics has picked up momentum in clinical practice, propelled by encouraging research. Since 2013 we've had several more radiopharmaceutical therapies get FDA approval. Since the U.S.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
AuntMinnie
JUNE 20, 2024
Food and Drug Administration's (FDA) approvals of radiopharmaceuticals for neuroendocrine tumors and then for prostate cancer, theranostics has picked up momentum in clinical practice, propelled by encouraging research. Since 2013 we've had several more radiopharmaceutical therapies get FDA approval. Since the U.S.
Imaging Technology
JANUARY 30, 2025
This 2024 update is the first revision since the initial AUC for amyloid PET was introduced in 2013. Since then, the U.S. Notably, the updated AUC introduces guidelines for tau PET imaging, paving the way for its broader clinical use following the FDAs approval of the tau radiotracer 18F-flortaucipir in 2020.
Imaging Technology
FEBRUARY 15, 2024
A rescan or re-injection of radiopharmaceutical to the patient may be required. 553 Date Initiated by Firm: December 15, 2023 Device Use The Philips Brightview system is a Single Photon Emission Computed Tomography ( SPECT ) machine used to take images showing biological activity in the human body, for medical personnel to review.
AuntMinnie
JANUARY 8, 2025
The update is the first revision since the initial guidance for amyloid PET was introduced in 2013, noted the two organizations in a January 8 announcement. Since then, the U.S. There are three PET radiotracers labeled with F-18 approved by the U.S.
Imaging Technology
JANUARY 14, 2025
This 2024 update is the first revision since the initial AUC for amyloid PET was introduced in 2013. Since then, the U.S. Notably, the updated AUC introduces guidelines for tau PET imaging, paving the way for its broader clinical use following the FDAs approval of the tau radiotracer 18F-flortaucipir in 2020.
Expert insights. Personalized for you.
207 
Let's personalize your content